Merck and Sanofi buy smaller cancer drug firms at big premiums, fueling investor excitement
ADOBE
The purchase prices, in each case more than double the smaller company’s market capitalization, will fuel investors’ excitement for biotech deals.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario